Clinical Trials Logo

Filter by:
NCT ID: NCT03779620 Completed - Clinical trials for Aortic Valve Stenosis

Valvosoft First-In-Man Study in Severe Symptomatic Aortic Stenosis

Start date: March 13, 2019
Phase: N/A
Study type: Interventional

This is a prospective, controlled, single-arm clinical investigation for the treatment of subjects with severe symptomatic aortic valve stenosis using Valvosoft® Pulsed Cavitational Ultrasound Therapy (PCUT) - First-In-man

NCT ID: NCT03779178 Completed - Atrial Fibrillation Clinical Trials

Landiolol in Postoperative Atrial Fibrillation

MMELPOAF
Start date: January 17, 2019
Phase: Phase 3
Study type: Interventional

Postoperative atrial fibrillation is a common complication after cardiac surgery and is associated with an elevation of morbidity and mortality. The recommended treatment includes heart rate control with a beta blocker. Landiolol is a new-generation beta-blocker with favourable pharmacologic properties making an interesting drug to treat postoperative atrial fibrillation. However, Landiolol micro and macrocirculatory effects in the setting of atrial fibrillation are yet to describe. The aim of this study is to describe microcirculatory effects of incremental doses of landiolol in postoperative atrial fibrillation compared to a placebo. Our hypothesis is Landiolol will improve microcirculation disorders.

NCT ID: NCT03779152 Completed - Asthma Clinical Trials

Regulation of CCL18 by Corticosteroids in Severe Asthma

CCL18
Start date: February 2009
Phase:
Study type: Observational

The majority of asthmatic patients are well controlled by inhaled corticosteroid treatment, however some severe asthma resist this treatment. CCL18 is a target gene for corticosteroids and its dysfunction may correlate with phenotypes of asthma.

NCT ID: NCT03778840 Completed - Autoimmune Diseases Clinical Trials

Study of Infections in Patients With Autoimmune Diseases Treated With Rituximab

EXPRIME
Start date: May 29, 2019
Phase:
Study type: Observational

Rituximab is a very effective drug used to treat many inflammatory diseases. These diseases include, for example, rheumatoid arthritis, multiple sclerosis and systemic autoimmune diseases. The major drawback of this drug is the risk of infection, which are favored by the direct effect of rituximab on the immune system. The risk of infection is one of the major reason not to prescribe or withdraw rituximab in several patients. However, many questions remain unanswered regarding the proportion and risk factors of infection or immunodeficiency induced by rituximab. Better understanding of these issues will help prescribing rituximab and properly monitor patients during their treatment. Moreover, as treatment with substitutive immunoglobulins might be a solution to decrease the risk of infections in those patients, it is very important to better characterize the risk and risk factors of rituximab-associated infection. The present study aims to answer these questions.

NCT ID: NCT03777618 Completed - Weight Loss Clinical Trials

Volumetric Study of the Buttocks After Flap Augmentation in Buttocks Lifting

Start date: September 1, 2018
Phase:
Study type: Observational

The development of bariatric surgery, its effectiveness and the reduction of complications are at the origin of massive weight loss, the corollary of which has been a clear increase in the demands of treatment of sequelae of weight loss.

NCT ID: NCT03777488 Completed - Clinical trials for Healthy Volunteer Study

Pharmacokinetics of Tranexamic Acid After Oral, Intramuscular or Intravenous Administration: a Prospective, Randomised, Cross-over Trial in Healthy Volunteers.

PharmacoTXA
Start date: October 30, 2019
Phase: Phase 1
Study type: Interventional

This is a Phase 1 study which aims to determine the pharmacokinetics and local and systemic tolerance of tranexamic acid in healthy volunteers using a population approach after oral, intramuscular or intravenous administration. It will also determine the feasibility of measuring tranexamic acid in spots of dry capillary blood.

NCT ID: NCT03777436 Completed - Psoriasis Clinical Trials

An Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate to Severe Genital Psoriasis

DISCREET
Start date: February 11, 2019
Phase: Phase 3
Study type: Interventional

This Phase 3 multicenter, randomized, placebo-controlled, double-blind study is designed to evaluate the efficacy and safety of apremilast in subjects with moderate to severe genital psoriasis (modified sPGA-G ≥3, moderate or severe). Approximately 286 subjects with moderate to severe genital psoriasis will be randomized 1:1 to receive either apremilast 30 mg BID or placebo for the first 16 weeks.

NCT ID: NCT03777397 Completed - Breast Cancer Clinical Trials

Awareness About Breast Cancer Screening

DEPSEIN_HCL
Start date: January 24, 2019
Phase:
Study type: Observational

Breast cancer is the most common cancer in French women, with 52000 new cases each year. Shift work and night work is recognized by International Agency for Research on Cancer as a potential risk factor. Epidemiological studies find, for most of them, an increased risk of breast cancer compared with general population. Physiological hypothesis rely on the melatonin role in defense against tumorigenesis. According to High Authority of Health clinical good practice guidelines, the risk does not justify more screening than the organized screening. We do not have information about awareness level of workers in health structures, specially in the Hospices Civils de Lyon. Investigators would like to know how employees take part to breast cancer screening, specially in night workers. This study, as a survey, is a first step to evaluate the need for specific actions to increase the participation to breast cancer screening.

NCT ID: NCT03776773 Completed - Allergic Rhinitis Clinical Trials

Impact of Pollution on Allergic Rhinitis and Sleep Quality: the POLLAR Study

POLLAR
Start date: April 8, 2019
Phase: N/A
Study type: Interventional

It has been demonstrated that allergic rhinitis (AR) reduces sleep quality by some components such as nasal obstruction. Pollution and allergen exposure worsening AR, sleep quality is deteriorated. Sleep is associated to physical and mental health, alterations in sleep could explain the link between AR and work productivity diminution, impairment in daily activities or emotional problems. However, interactions between air pollution, sleep and allergic diseases are insufficiently understood. The main objective of this study is to determine the impact of pollution and pollens on sleep parameters.

NCT ID: NCT03776708 Completed - Spinal Manipulation Clinical Trials

Effect of Spinal Manipulation on Experimental Pain in Asymptomatic Subjects.

Start date: October 1, 2018
Phase: N/A
Study type: Interventional

Spinal manipulation is often used for its effect on pain, but more information is needed concerning its mechanisms of action.